TY  - JOUR 
AU  - Abbruzzese, Giovanni
AU  - Kulisevsky Bojarsky, Jaume
AU  - Bergmansº, Bruno
AU  - Gómez Esteban, Juan Carlos
AU  - Kägi, Georg
AU  - Stefani, Alessandro
AU  - Warnecke, Tobias
AU  - Jost, Wolfgang H.
AU  - Cubo Delgado, Esther
AU  - SYNAPSES Study Investigators Group
PY  - 2021
SN  - 1877-7171
UR  - http://hdl.handle.net/10259/8816
AB  - Background:
Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson’s disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in...
LA  - eng
PB  - IOS Press
KW  - Parkinson’s disease
KW  - Safinamide
KW  - MAO-B inhibitor
KW  - Real-life evaluation
KW  - Sistema nervioso-Enfermedades
KW  - Nervous system-Diseases
KW  - Medicina
KW  - Medicine
KW  - Neurología
KW  - Neurology
TI  - A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial
DO  - 10.3233/JPD-202224
T2  - Journal of Parkinson's Disease
VL  - 11
M2  - 187
ER  -